Molecule

Stage: Series A

Get updates & announcements

About

Molecule is a decentralized biotech protocol, building a web3 marketplace for research-related IP. Their platform and scalable framework for biotech DAOs connects academics and biotech companies with quick and easy funding, while enabling patient, researcher, and investor communities to directly govern and own research-related IP.

Contact Details

https://mail.google.com/mail/u/0/?fs=1&tf=cm&source=mailto&to=info@molecule.to

https://www.molecule.to

https://www.molecule.to/blog

Community Affiliations

Members (15)

Aaron Weaver

President

Paul Kohlhaas

Co-Founder & Executive Chairman

Tyler Golato

Co-Founder & CEO

Show All Members

Focus Areas

Projects (1)

Catalyst

A funding and review platform for translational science.

Molecule News (6)

Molecule publishes research paper mapping Onchain Labs to Google DeepMind's agentic…

A new technical post shows how Molecule's Onchain Lab primitive satisfies every mechanism in DeepMind's autonomous scientific discovery model, from data gating to agent permissions.

Fundingmolecule.to20d ago

188 Views

Molecule team presents in Zürich on agentic AI in drug discovery

The team announced it will speak at a RoX Health event hosted by Roche's digital health studio on Sep 23, covering agentic models and lab-in-the-loop discovery.

Announcement1 month ago

40 Views

BioProtocol announced OpenLabs at DeSci Berlin, a coordination and collaboration layer for AI-assisted research funding; the platform integrates Molecule's "Labs" product to…

Jun 19, 2026 — BioProtocol announced OpenLabs at DeSci Berlin, a coordination and collaboration layer for AI-assisted research funding; the platform integrates Molecule's "Labs" product to verifiably track and report scientific progress from idea to funded execution.

Fundingcrypto.news4 months ago

23 Views

All network updates